It won’t help.
Before we get into the gist of today’s post a short history of acquisitions in the insulin pump space.
Way back in the day there were two major players MiniMed and Disetronic. Back in 2003 Roche paid $1.2 Billion for Disetronic and promptly ran the company into the ground. Not content to run just one insulin pump company into the ground Roche doubled down and in 2010 spent another $160 million to acquire Medingo the makers of the Solo Patch Pump. Here we are more than 10 years after the Medingo acquisition, and the Solo is where?
In . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.